this format not displayed properly, please click
download a press release.
Jouhou Koukai is celebrating its second
Its newly designed web site
features improved interface to facilitate the navigation
and to provide better access to all documents and services
offered. The site also became fully searchable .
JKS this month
For two years the site became the leading
source of documents, regulatory information, intelligence and consulting
services on the Japanese pharmaceutical market, and its popularity is on the rise. As the results from a recently commissioned
e-health benchmarking study show in using the three top keywords
describing our activities -
pharma disclosure Japan the
ranking by the major search engines are:
Our core contribution is the
Japanese Approvals Database (JAD)
- constantly updated and now spanning over five years from 1999 to the
latest pharmaceutical products registered in Japan in January 2003.
At present, the JAD is the most comprehensive and only English-language
database of the medicinal products registered in Japan. In its latest update
the JAD contains data for nearly 300 products divided in two categories
- product description and documents. Under the category of product
description the manufacturer, approved formulations, brand (trade) name,
generic name and c0-marketing partners are listed. The documents data
include the availability and the latest version of the Package Inserts
(PI), the Evaluation Report (of the regulatory authorities) and the
Japanese equivalent of the Summary Basis of Approval (SBA).
Predominantly, those documents are available in Japanese, as for our
overseas clients both content analysis and/or full translation into
English are offered as a part of our consulting and advisory services.
Available at the web site of JKS are
several repositories and collections of documents related to the
Public Access to Information Law (PAIL),
regulatory information, laws,
Ministry of Health, Labor and Welfare regulations,
other source documents and
news relevant to the pharmaceutical
affairs, and pharmaceutical/medical device industry
Enhancements of services
Starting from 2003,
along with the maintenance of the JAD and retrieval of disclosed
documents, JKS is upgrading its
consulting capabilities to capitalize on its unparalleled
expertise with the Japanese regulatory documents and regulations. Part
of the expansion focuses on the primary medical market research
targeting physicians and the trends in prescription drugs.
Forthcoming is the JKS Partnership
Program - with regulatory agencies and professional partners around the
world, and the announcement for the new appointments to the JKS's
Advisory Board of international experts and prominent academics.
Tell + Voice Mail:
follow the instructions
Koukai Services LLC was established in 2001 to provide
services under the
Law Concerning Access to Information
Held by Administrative Organs enforced in Japan
on April 1, 2001.The Law - also known as is equivalent to the
US Freedom of Information Act
(FOIA) and considered of significant interest for the
worldwide healthcare, pharmaceutical,
biotechnological, medical devices and allied industries.
have received this newsletter as a service from JKS. To
send comments or to unsubscribe from this newsletter, send a